FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 2

Author

Admin 424 posts 0 comments

Articles

Utilizing Procurement Tools for Businesses in the Modern Era

Admin Jul 27, 2026
In today’s fast-paced business landscape, effective procurement processes are pivotal for maintaining a…
Articles

How Fintech is Revolutionizing Personal Finance Management

Admin Jul 24, 2026
Financial technology (fintech) has dramatically changed the landscape of personal finance, offering consumers more…
Whitepaper

The Modernization of Payments and the New Bank Tech Company

Admin Jul 23, 2026
The writing is on the wall. Disruptive technologies, evolving consumer behaviors and expectations, innovative new…
Whitepaper

Central Bank Digital Currency Global Interoperability Principles

Admin Jul 21, 2026
Central banks have different motivations for exploring or developing central bank digital currency (CBDC), and the…
Articles

How to Calculate the Effect of Physical Risks on Finance

Admin Jul 20, 2026
Acute physical risks from climate change can be caused by storms or floods, or they can be chronic, resulting from…
Articles

Five things not to do while financial planning

Admin Jul 17, 2026
Many women rely on their parents or spouses for financial planning and investment responsibilities because it has…
Whitepaper

Artificial Intelligence, Machine Learning and Big Data in Finance

Admin Jul 16, 2026
Artificial Intelligence (AI) techniques are being increasingly deployed in finance, in areas such as asset…
Whitepaper

Plan Sponsor Reporting and Audit Guide

Admin Jul 15, 2026
Unlike many trusteed plans, a retirement plan using TIAA and CREF annuities may be funded, in whole or in part, by…
Whitepaper

Real-time payments: A perspective for payment system policy makers

Admin Jul 14, 2026
As the name suggests, real-time payment systems accelerate the speed at which funds are transferred between…
Articles

The Share Market and Systematic Investment Plans (SIPs): A Guide to Smart…

Admin Jul 13, 2026
The share market has long been a significant avenue for individuals seeking to build wealth through…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape
    • Why Financial Services and Banks Need an Operational Data Layer
    • FinTech Futures: How Media, Advertising & Marketing Are Shaping the Next Generation of Financial Services

    ARTICLE

    Biomimetic Innovations Ltd announces First-in-Human application of OsStic™ Injectable Synthetic Bone Void Filler
    2026-08-12T12:30:00Z
    SHANNON, Ireland, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Biomimetic Innovations Ltd, an affiliate of PBC Biomed - an Irish medical device company specialising in biomimetic materials, today announced the successful...


    Mapi Pharma Announces Initial Phase I/IIa Clinical Results Supporting Continued Development of Once-Monthly Cariprazine Depot
    2026-08-12T12:30:00Z
    NESS ZIONA, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd. (“Mapi” or the “Company”), a late-stage clinical biopharmaceutical company specializing in long-acting injectable therapies, today announced initial clinical...


    Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
    2026-08-12T12:30:00Z
    Initiatives Provide New DYANAVEL® XR Patients With Digital Wellness Resources and Practical Organization Tools Designed to Support ADHD Care Beyond Medication


    Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
    2026-08-12T12:30:00Z
    Dyadic to host earnings call on August 12 at 5:00 pm ET


    Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
    2026-08-12T12:30:00Z
    Contrasting Science with Revolution Medicines and Erasca


    Aprea Therapeutics Announces Second Quarter 2026 Financial Results
    2026-08-12T12:30:00Z
    Enrollment in the ongoing Phase 1 dose escalation ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating as dose escalation advances


    Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
    2026-08-12T12:30:00Z
    Agreement combines Austrianova’s Cell-in-a-Box® technology with San Raffaele Hospital’s stem cell-derived beta cell expertise through a research collaboration with Avaí Bio and Austrianova’s JV Company, Insulinova, aimed at advancing an...


    SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
    2026-08-12T12:25:00Z
    TEL AVIV, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused...


    Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
    2026-08-12T12:15:00Z
    Final histology and laboratory analyses support the study’s safety and performance objectives


    SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
    2026-08-12T12:05:00Z
    Commercial launch supported by a dedicated national sales force, payer and institutional access, and multi-channel marketing campaign supporting adoption of REZENOPY™


    Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
    2026-08-12T12:00:00Z
    Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027


    Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
    2026-08-12T12:00:00Z
    PHILADELPHIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including T1D, and...


    Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
    2026-08-12T12:00:00Z
    HOUSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies...


    MUHC Foundation President and CEO Marie-Hélène Laramée appointed to Women’s Health Collective Canada Board of Directors
    2026-08-12T12:00:00Z
    Laramée’s appointment strengthens Quebec’s voice in the national movement to close gaps in women’s health research, care, and leadership


    Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026
    2026-08-12T12:00:00Z
    PHILADELPHIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to the...


    Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
    2026-08-12T12:00:00Z
    Milestone strengthens manufacturing flexibility and supports pivotal study readiness


    Reflect Scientific Reports More Than $1.4 Million in Freezer-System Sales to Biopharmaceutical Customers
    2026-08-12T12:00:00Z
    OREM, Utah, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF) today announced more than $1.4 million in delivered commercial freezer-system sales to six biopharmaceutical companies during the...


    Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
    2026-08-12T12:00:00Z
    CONSHOHOCKEN, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced it has...


    ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments
    2026-08-12T12:00:00Z
    – Ying Huang, Ph.D. appointed to Board of Directors, bringing deep experience spanning executive public biotech leadership, Wall Street and big pharma R&D –


    Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
    2026-08-12T11:30:00Z
    Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2


    BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
    2026-08-12T11:30:00Z
    Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025


    PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
    2026-08-12T11:30:00Z
    FDA Accepted D-PLEX₁₀₀ NDA with Priority Review; PDUFA Goal Date of November 28, 2026, Approximately One Quarter Ahead of Previously Communicated Guidance


    Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
    2026-08-12T11:30:00Z
    Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been...


    Altimmune Announces Second Quarter 2026 Financial Results and Business Update
    2026-08-12T11:30:00Z
    Initiated global PERFORMA Phase 3 trial in MASH


    Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:30:00Z
    Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M as of June 30, 2026


    Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality
    2026-08-12T11:12:02Z
    COPENHAGEN, Denmark, August 12, 2026 – Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the texture, firmness...


    Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:08:47Z
    Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST® (etripamil) nasal spray


    Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
    2026-08-12T11:05:00Z
    – Newly granted patent extends protection for ATH434 to at least 2045, significantly enhancing its strategic value and long-term commercial potential –


    Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
    2026-08-12T11:05:00Z
    REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare...


    TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:00:00Z
    First patient dosed in Phase 3 ALLOHA-2™ study; topline readout expected mid-2028

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.